```html

Jellyfish‑Associated Marine Bacterial Infection

Overview

Jellyfish‑associated marine bacterial infection (JAMBI) refers to a bacterial skin or soft‑tissue infection that follows contact with a jellyfish—most often after a sting, handling of tentacles, or immersion in water contaminated with jellyfish‑associated microbes. The bacteria are typically marine opportunists such as Vibrio spp., Edwardsiella tarda, Photobacterium spp., or Aeromonadaceae that exploit the skin barrier breach created by nematocyst discharge.

Who it affects: swimmers, surfers, divers, fishermen, and beach‑goers in warm coastal waters. In the United States, the majority of cases are reported in the Gulf of Mexico, the Atlantic seaboard of the southeastern states, and the Pacific coast of California and Hawaii. Similar patterns are seen in tropical regions of Southeast Asia, Australia, and the Mediterranean.

Prevalence: Precise incidence is difficult to determine because many cases are treated empirically as “stings” without bacterial cultures. However, surveillance data from the U.S. Centers for Disease Control and Prevention (CDC) indicate that approximately 10‑15 % of reported jelly‑fish stings develop a secondary bacterial infection, corresponding to an estimated 2,000–3,500 cases annually in the United States alone. In coastal Thailand, a retrospective study identified 112 culture‑confirmed Vibrio wound infections out of 1,048 jellyfish‑related injuries (≈10.7 %) over a five‑year period (Mahidol Univ. J Med 2022).

Symptoms

Symptoms may appear within hours after the sting or develop over several days as bacteria proliferate. The clinical picture can range from mild cellulitis to severe necrotizing infection.

Local skin findings

• Redness (erythema) – often spreading outward from the initial sting site.
• Swelling (edema) – may be disproportionate to the size of the sting.
• Pain or burning – typically worsens rather than improves after the initial sting.
• Heat – the area feels warmer than surrounding skin.
• Pustules or vesicles – may contain purulent fluid.
• Ulceration or necrosis – in severe cases, skin breakdown with blackened tissue.
• Discharge – serous, purulent, or foul‑smelling exudate.

Systemic signs

• Fever ≥ 38 °C (100.4 °F)
• Chills or rigors
• Generalized malaise, fatigue
• Muscle aches (myalgia)
• Nausea, vomiting, or diarrhea (especially with Vibrio spp.)
• Headache or dizziness

Causes and Risk Factors

Microbial culprits

The most frequently isolated organisms in JAMBI are:

• Vibrio vulnificus – thrives in warm (> 20 °C) seawater; most aggressive.
• Vibrio parahaemolyticus – common in estuarine environments.
• Edwardsiella tarda – associated with brackish water and fish.
• Photobacterium damselae – marine gram‑negative rod linked to wound infections.
• Aeromonas hydrophila – ubiquitous in freshwater and marine habitats.

How the infection occurs

1. Skin barrier breach – nematocyst discharge creates microscopic punctures.
2. Direct bacterial inoculation – tentacle mucus or surrounding water introduces bacteria.
3. Secondary colonization – after the initial inflammatory response, damaged tissue provides nutrients for bacterial growth.

Risk factors

• Recent jellyfish sting or handling of live tentacles.
• Open cuts, abrasions, or eczema on exposed skin.
• Immunocompromised state (e.g., diabetes, chronic liver disease, HIV, chemotherapy).
• Chronic liver disease – markedly increases risk of severe Vibrio infection (up to 70 % mortality in fulminant cases) [CDC, 2021].
• Older age (> 65 years) and peripheral vascular disease.
• Exposure to warm coastal waters (sea surface temperature > 25 °C).
• Delayed or inadequate first‑aid (failure to rinse with seawater, not removing tentacle remnants).

Diagnosis

Clinical assessment

Diagnosis begins with a detailed history (date of exposure, type of jellyfish, wound care) and a thorough physical exam focusing on the lesion’s size, depth, and signs of systemic infection.

Laboratory tests

• Wound culture – swab or tissue biopsy sent for aerobic and anaerobic Gram‑negative cultures; essential for targeted therapy.
• Blood cultures – indicated if fever, hypotension, or signs of bacteremia are present.
• Complete blood count (CBC) – leukocytosis with left shift suggests bacterial infection.
• Serum chemistry – assess renal and liver function, especially before using nephrotoxic antibiotics.
• Inflammatory markers – CRP and ESR often elevated but nonspecific.

Imaging (when needed)

• Ultrasound – evaluates for fluid collections/abscesses in superficial tissue.
• CT or MRI – employed if deep fascial involvement, osteomyelitis, or necrotizing soft‑tissue infection is suspected.

Diagnostic criteria (simplified)

A diagnosis of JAMBI is made when all of the following are present:

1. Recent (< 72 h) exposure to jellyfish or marine environment.
2. Evidence of a breached skin barrier (sting, abrasion).
3. Local or systemic signs of bacterial infection.
4. Positive culture for a marine gram‑negative organism OR a clinical response to appropriate antimicrobial therapy.

Treatment Options

First‑aid measures (immediate)

1. Rinse with seawater – fresh water can cause additional nematocyst discharge.
2. Remove tentacle remnants using tweezers; avoid rubbing.
3. Apply a cold pack for pain and edema.
4. Topical vinegar (4 % acetic acid) – helps neutralize nematocysts for certain species (e.g., box jellyfish).

Antibiotic therapy

Empiric coverage should target marine Gram‑negative rods, especially Vibrio spp.

Agent	Typical dose (adult)	Key notes
Doxycycline 100 mg PO BID	7–14 days	First‑line for Vibrio; good tissue penetration.
Ceftriaxone 1–2 g IV q24 h	7–14 days	Alternative when doxycycline contraindicated.
Levofloxacin 750 mg PO daily	7–10 days	Effective against many marine Gram‑negatives; watch for QT prolongation.
Combination (Doxycycline + Ceftriaxone)	Severe infection or immunocompromised	Reduces risk of treatment failure.

For patients allergic to tetracyclines or with renal insufficiency, fluoroquinolones (ciprofloxacin, levofloxacin) or third‑generation cephalosporins are acceptable alternatives.

Surgical interventions

• Incision & drainage (I&D) – indicated for abscesses or fluctuance.
• Debridement – removal of necrotic tissue in necrotizing fasciitis; may require serial procedures.
• Amputation – rare, reserved for life‑threatening gangrene.

Adjunctive therapies

• Analgesia – NSAIDs (if no contraindication) or acetaminophen for pain control.
• Fluid resuscitation – especially for septic patients.
• Hyperbaric oxygen – considered for refractory necrotizing infections, though evidence is limited.

Lifestyle & supportive care

• Elevate the affected limb to reduce edema.
• Keep the wound clean and covered with a sterile dressing.
• Complete the full antibiotic course, even if symptoms improve.

Living with Jellyfish‑Associated Marine Bacterial Infection

Daily wound care

1. Gently cleanse the area twice daily with mild soap and sterile saline.
2. Apply a thin layer of petroleum‑jelly or an antibiotic ointment (e.g., bacitracin) if advised.
3. Change dressings at least once daily or sooner if they become wet or soiled.
4. Monitor for increasing redness, swelling, warmth, or drainage.

Activity modifications

• Avoid swimming, hot tubs, or submerging the wound until cleared by a clinician (usually 48–72 h after starting antibiotics).
• Wear protective waterproof dressings if you must be in water (e.g., neoprene “wet‑suit” sleeves with sealed seams).
• Schedule follow‑up appointments within 48 h of starting therapy to assess response.

Managing comorbidities

Control blood glucose, maintain adequate nutrition, and manage chronic liver disease to improve healing and reduce recurrence risk.

Psychological aspect

Fear of returning to the ocean is common. Counseling, gradual exposure therapy, or joining a support group for beach‑goers can help reduce anxiety.

Prevention

• Know the season – jellyfish blooms peak in late summer; avoid high‑density areas during these periods.
• Protective clothing – wear full‑body Lycra “stinger suits” or wetsuits in endemic zones.
• Use barrier creams containing zinc oxide; they may reduce nematocyst discharge.
• Promptly rinse with seawater (not fresh) if stung, then remove tentacles with tweezers.
• Report beach closures – local health departments often post jellyfish alerts.
• Vaccination – no specific vaccine exists, but staying up to date on tetanus and hepatitis A/B is advisable for marine exposures.
• Educate children – teach them not to touch jellyfish, even “dead” ones.

Complications

If left untreated or inadequately treated, JAMBI can progress to serious sequelae:

• Cellulitis progressing to necrotizing fasciitis – rapid tissue death, requires emergent surgery.
• Septicemia – especially with Vibrio vulnificus; mortality up to 25 % in healthy adults and > 50 % in patients with liver disease.
• Osteomyelitis – infection of underlying bone, often requiring prolonged antibiotics (6‑12 weeks) and possible debridement.
• Chronic ulceration or scarring – may lead to functional limitation or cosmetic concerns.
• Renal failure – secondary to sepsis or nephrotoxic antibiotics if not monitored.

When to Seek Emergency Care

References

• Mayo Clinic. “Vibrio infections.” https://www.mayoclinic.org. Accessed May 2026.
• CDC. “Vibrio vulnificus.” Centers for Disease Control and Prevention, 2021. https://www.cdc.gov.
• World Health Organization. “Marine and freshwater infections.” WHO Fact Sheets, 2022.
• Cleveland Clinic. “Jellyfish Stings and Infections.” https://my.clevelandclinic.org.
• Mahidol University Journal of Medicine. “Marine bacterial wound infections after jellyfish injuries in Thailand, 2017‑2021.” 2022.
• NIH National Library of Medicine. “Necrotizing fasciitis associated with Vibrio infections.” Clinical Infectious Diseases, 2020.

```